Secondary c-kit mutation in a recurrent gastrointestinal stromal tumor under long-term treatment with imatinib mesylate: report of a case. [electronic resource]
- Surgery today 2008
- 65-7 p. digital
Publication Type: Case Reports; Journal Article
0941-1291
10.1007/s00595-007-3559-8 doi
Aged Antineoplastic Agents--therapeutic use Benzamides DNA, Neoplasm--genetics Exons Follow-Up Studies Gastrointestinal Stromal Tumors--diagnosis Humans Imatinib Mesylate Male Neoplasm Recurrence, Local--diagnosis Piperazines--therapeutic use Point Mutation Protein-Tyrosine Kinases--antagonists & inhibitors Proto-Oncogene Proteins c-kit--genetics Pyrimidines--therapeutic use Time Factors Tomography, X-Ray Computed